Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1981-1-29
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0022-3476
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
97
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
834-6
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:7000997-Bone Diseases, Developmental,
pubmed-meshheading:7000997-Heart Defects, Congenital,
pubmed-meshheading:7000997-Humans,
pubmed-meshheading:7000997-Hyperostosis, Cortical, Congenital,
pubmed-meshheading:7000997-Infant,
pubmed-meshheading:7000997-Male,
pubmed-meshheading:7000997-Prostaglandins E
|
pubmed:year |
1980
|
pubmed:articleTitle |
Cortical hyperostosis following long-term administration of prostaglandin E1 in infants with cyanotic congenital heart disease.
|
pubmed:publicationType |
Journal Article,
Case Reports
|